What Андрогель Treats: Main Uses and Benefits

The medication is used as Testosterone Replacement Therapy (TRT) for adult males with the diagnosis of hypogonadism, a condition characterized by symptoms related to systemic imbalance. It is commonly used to help with Primary Hypogonadism and Hypogonadotropic Hypogonadism.

---

Core Therapeutic Focus

This therapy addresses the complex array of symptoms related to systemic imbalance, which often involve episodic or fluctuating manifestations. It is commonly used in chronic situations relevant when supportive symptom management is appropriate, and relevant for easing the symptoms that create noticeable physiological strain. The primary symptomatic domains it may be part of symptomatic management include sexual function, psycho-cognitive distress, and symptoms related to physical discomfort.

Quick Fact: Support for Systemic Imbalance	Property	Description
Therapeutic Role	Supportive treatment for hormone deficiency symptoms.
Primary Indication	Hypogonadism (Primary and Hypogonadotropic forms).
Key Benefits	Supports general well-being during symptomatic phases and assists with maintaining functional stability.
Usage Context	Applied in chronic situations requiring long-term replacement support.

The treatment may assist with managing manifestations such as pronounced decreased libido, erectile dysfunction, persistent fatigue, mood depression, and other symptoms related to physical discomfort. This supportive care contributes to improved day-to-day comfort.

Regulatory References

1. FDA Prescribing Information for Testosterone Gel

AndroGel is approved by regulatory bodies for use only in adult males who have a documented deficiency or absence of endogenous testosterone, known as hypogonadism, which must be confirmed by morning serum testosterone measurements on at least two separate days.

Contraindicated Populations

Use is absolutely contraindicated for:

• Men with carcinoma of the breast or known or suspected carcinoma of the prostate.
• Pregnant or breastfeeding women due to the risk of fetal harm and potential for serious adverse effects in nursing infants.

Use Restrictions and Unestablished Groups

The gel is not indicated for use in women or in males less than 18 years old, as safety and efficacy in these groups have not been established. Use is also not established for treating low testosterone solely due to aging (age-related hypogonadism).

Special caution and monitoring are required for patients with pre-existing conditions such as cardiac, renal, or hepatic disease due to the risk of fluid retention and edema, and for those with Benign Prostatic Hyperplasia (BPH) who require monitoring for worsening symptoms. Patients with uncontrolled hypertension are also restricted from using certain formulations.

Interactions with other medicines and products

Therapy with Андрогель (testosterone gel) requires monitoring when used concurrently with certain medications to manage potential interaction risks.

Key Interacting Medicinal Product Categories:

Product Category	Interaction Mechanism and Constraint
Oral Anticoagulants	Androgens may alter anticoagulant activity, potentially leading to increased risk. More frequent monitoring of the International Normalized Ratio (INR) and prothrombin time is recommended, particularly at the initiation and termination of the gel therapy.
Antidiabetic Agents (e.g., Insulin)	Androgens may decrease blood glucose levels, potentially resulting in decreased requirements for insulin or other antidiabetic medications in diabetic patients. Adjustment of the antidiabetic agent dosage may be necessary.
Corticosteroids or ACTH	Concurrent use of testosterone with adrenocorticotropic hormone (ACTH) or corticosteroids may lead to increased fluid retention. This requires careful use and monitoring, especially in individuals with existing cardiac, renal, or hepatic disease.

Secondary Exposure Restriction

The most significant constraint relates to the potential for secondary exposure to testosterone. Women and children must strictly avoid contact with unwashed or unclothed skin where the gel was applied. Secondary exposure carries the risk of virilization (development of male characteristics) in these individuals. Patients are advised to cover the application site with clothing once the gel has dried and to wash their hands thoroughly after application.

Андрогель is a transdermal formulation containing the natural androgen testosterone. Following application, the testosterone is absorbed into the systemic circulation, where it primarily acts as an agonist at the intracellular androgen receptor (AR).

Testosterone, or its potent metabolite dihydrotestosterone (DHT) formed by 5alpha-reductase, binds to the AR in the target cell cytoplasm. This ligand binding induces dissociation from heat shock proteins, leading to translocation of the steroid-receptor complex into the cell nucleus. The complex then binds to specific DNA sequences known as androgen response elements (AREs) on target genes. This interaction modulates gene transcription, altering the synthesis rate of specific messenger RNAs and subsequently modulating protein synthesis across various tissues, including muscle, bone, and reproductive tissues. System-level consequences include the modulation of nitrogen retention, protein anabolism, erythropoiesis, and feedback inhibition of the hypothalamic-pituitary-gonadal (HPG) axis by suppressing the release of pituitary luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

The use of Андрогель (testosterone gel) is strictly governed by official prescribing information. The medication is administered via the topical route for transdermal absorption and is intended exclusively for adult males.

---

Administration Scope

The preparation is applied once daily, preferably in the morning, to clean, dry, and intact skin. Approved application sites include the shoulders and upper arms; the abdomen may be used for the 1% concentration but is typically excluded for the 1.62% concentration. It must not be applied to the genitals.

The standard starting dose varies by concentration. The 1% gel typically starts at 50 mg of testosterone daily, with adjustments possible up to a maximum of 100 mg. The 1.62% gel typically starts at 40.5 mg daily, with a maximum dose of 81 mg of testosterone.

---

Procedural Conditions and Schedule

For accurate dosing, the multi-dose pump requires priming prior to the first use. The dose is not adjusted based on symptoms but on the measurement of pre-dose serum testosterone concentration. This measurement is recommended approximately 14 days after initiation of treatment or following any dose change. This protocol ensures the therapy maintains long-term replacement support within the normal physiological range.

Post-application requirements dictate that the user must thoroughly wash hands with soap and water and allow the gel to dry completely before getting dressed. Furthermore, clinical guidelines advise waiting at least one hour after application before showering or bathing.

Androgel: Recent Clinical Evidence

Overview of Research Studies

Research has explored the role of testosterone gel in individuals with confirmed hypogonadism (low testosterone levels). Studies have investigated whether the use of testosterone replacement therapy is associated with changes in various clinical markers, including bone mineral density, body composition, and sexual function.

Early-stage trials focused on the safety profile and on establishing the pharmacokinetic properties of the transdermal delivery system. These initial studies helped to determine how the active ingredient is absorbed through the skin and what blood concentration levels are typically observed in trial participants.

Key Study Findings

Confirmatory Phase 3 trials evaluated the long-term application of testosterone gel across diverse populations of hypogonadal men. The primary endpoints in these studies often related to the normalization of serum total testosterone concentration. Research has also examined secondary outcomes related to quality of life.

Area of Investigation	Relationship Observed in Studies
Sexual Function	Studies investigated a relationship between testosterone gel use and patient-reported measures of libido and erectile function.
Body Composition	Research tracked changes in lean body mass and fat mass during the evaluation period.
Bone Health	Trials evaluated potential effects on bone mineral density, especially in the lumbar spine and hip areas.

Data from these trials reflect outcomes for patients starting therapy, noting that individual response to treatment can vary.

Common questions about Андрогель (FAQ)

Q: What is Андрогель?

A: Андрогель (Androgel) is a prescription medication used for testosterone replacement therapy (TRT). It is a topical gel applied to the skin to supplement or replace the body's natural testosterone in men who have low levels (a condition called hypogonadism).

Q: What does testosterone do in the male body?

A: Testosterone is the primary male sex hormone, an androgen, naturally produced in the testicles. It is essential for:

• The development and maintenance of male physical characteristics (e.g., muscle mass, bone density, facial and body hair).
• Maintaining sex drive (libido).
• Controlling mood and energy levels.
• The production of sperm.

Q: How is Андрогель applied?

A: Андрогель is applied once daily at approximately the same time, preferably in the morning.

It should be applied to clean, dry, intact skin of the shoulders and/or upper arms. It is important to apply it only to these recommended areas. Do not apply to the genitals, chest, abdomen, or knees.

After applying, allow the gel to dry completely before dressing. Wash your hands thoroughly with soap and water immediately after application.

Q: When can I shower or swim after applying Андрогель?

A: It is recommended to wait at least two to six hours after application before showering, swimming, or washing the application site. This waiting period helps ensure the body fully absorbs the medication.

Q: Can women or children come into contact with the application site?

A: No. This is a critical safety precaution. Testosterone can be transferred to others through skin contact and can cause serious adverse effects, particularly in women and children.

To prevent transfer:

• Cover the application site with clothing (a T-shirt or long-sleeved shirt) once the gel is dry.
• If skin-to-skin contact is anticipated, thoroughly wash the application site with soap and water beforehand.

Signs of accidental exposure in children may include enlarged genitals, premature pubic hair development, increased erections, or aggressive behavior. Signs in women may include changes in body hair or acne.

Q: What are some potential side effects of Андрогель?

A: Common side effects may include:

• Skin reactions at the application site (e.g., irritation, redness, dryness).
• Increase in Prostate-Specific Antigen (PSA) levels.
• Acne or other skin changes.
• Changes in mood.
• Hair loss.

Serious potential side effects, which require immediate medical attention, include symptoms related to blood clots (pain, swelling, warmth in the legs), sleep apnea, or heart problems.

Q: How long does it take for Андрогель to work?

A: While some men may begin to feel benefits like improved energy or libido within a few weeks, the full therapeutic effects on muscle mass, bone density, and mood may take several months of consistent use.

Your healthcare provider will monitor your blood testosterone levels regularly, usually after 14 to 28 days of treatment, to ensure the dose is correct.

Q: What should I tell my doctor before starting Андрогель?

A: Before starting treatment, you must inform your doctor about your complete medical history, especially if you have or have had:

• Prostate cancer or breast cancer (Androgel is contraindicated).
• Severe heart, kidney, or liver disease.
• Sleep apnea.
• Benign prostatic hyperplasia (BPH) or other prostate issues.
• Diabetes or high blood pressure.

Also, disclose all other medications you are taking, including prescription and non-prescription drugs, vitamins, and herbal supplements, as they may interact with testosterone therapy.

Storage and Disposal Requirements for AndroGel (Testosterone Gel)

AndroGel must be stored and handled according to specific regulatory requirements to maintain product stability and prevent accidental exposure.

Storage and Safety

Requirement	Details
Temperature	Store at Controlled Room Temperature, 25 C (77 F), with permitted excursions up to 30 C (86 F).
Container	Keep in the original container, tightly closed, and protect from moisture and light.
Flammability	Avoid fire, flame, or smoking until the applied gel has thoroughly dried, as the product is flammable.
Child Safety	Keep out of the reach of children and store in a safe, secure place to prevent accidental use.

Disposal Instructions

Disposal procedures must be followed for unused product. Do not flush unused or expired medicine down the toilet or pour it into a drain. Consult a healthcare professional or local waste disposal company for guidance on proper disposal. Empty containers (pumps, tubes, or packets) must be thrown away in a location inaccessible to children and pets.